Haloderm Advanced

Dulcamara, Nitricum Acidum, Thuja Occidentalis, Antimonium Crudum, Calcarea Carbonica, Silicea


Haloderm, Inc.
Human Otc Drug
NDC 71950-0001
Haloderm Advanced also known as Dulcamara, Nitricum Acidum, Thuja Occidentalis, Antimonium Crudum, Calcarea Carbonica, Silicea is a human otc drug labeled by 'Haloderm, Inc.'. National Drug Code (NDC) number for Haloderm Advanced is 71950-0001. This drug is available in dosage form of Paste. The names of the active, medicinal ingredients in Haloderm Advanced drug includes Antimony Trisulfide - 12 [hp_X]/g Nitric Acid - 10 [hp_X]/g Oyster Shell Calcium Carbonate, Crude - 12 [hp_X]/g Silicon Dioxide - 12 [hp_X]/g Solanum Dulcamara Top - 10 [hp_X]/g Thuja Occidentalis Leafy Twig - 10 [hp_X]/g . The currest status of Haloderm Advanced drug is Active.

Drug Information:

Drug NDC: 71950-0001
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Haloderm Advanced
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Dulcamara, Nitricum Acidum, Thuja Occidentalis, Antimonium Crudum, Calcarea Carbonica, Silicea
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Haloderm, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Paste
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ANTIMONY TRISULFIDE - 12 [hp_X]/g
NITRIC ACID - 10 [hp_X]/g
OYSTER SHELL CALCIUM CARBONATE, CRUDE - 12 [hp_X]/g
SILICON DIOXIDE - 12 [hp_X]/g
SOLANUM DULCAMARA TOP - 10 [hp_X]/g
THUJA OCCIDENTALIS LEAFY TWIG - 10 [hp_X]/g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 26 Feb, 2018
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 04 Jan, 2024
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 06 May, 2026
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Haloderm, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:F79059A38U
411VRN1TV4
2E32821G6I
ETJ7Z6XBU4
KPS1B1162N
1NT28V9397
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
71950-0001-15 g in 1 TUBE (71950-0001-1)26 Feb, 201804 Jan, 2024No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Indications: homeopathic formula to target benign mole and skin tag symptoms.

Product Elements:

Haloderm advanced dulcamara, nitricum acidum, thuja occidentalis, antimonium crudum, calcarea carbonica, silicea solanum dulcamara top solanum dulcamara top nitric acid nitric acid thuja occidentalis leafy twig thuja occidentalis leafy twig antimony trisulfide antimony trisulfide oyster shell calcium carbonate, crude oyster shell calcium carbonate, crude silicon dioxide silicon dioxide water sanguinaria canadensis root glycerin zinc chloride polyethylene glycol 1500 peg-8 dimethicone polyethylene glycol 700 propylene glycol diazolidinyl urea iodopropynyl butylcarbamate

Indications and Usage:

Indications: homeopathic formula to target benign mole and skin tag symptoms.

Warnings:

Warnings: for external use only: keep out of eyes and away from mucous membranes

Dosage and Administration:

Directions: adults & children 13 years & over - apply only enough to coat the entire blemish. for first use leave on for 45 minutes and cover with bandage. if a second coat is needed, leave on over night. repeat if necessary.

Package Label Principal Display Panel:

Package label display: haloderm homeopathic mole & skin tag remover .17 oz (5g) advanced haloderm advanced

Further Questions:

Questions: haloderm inc, carlsbad, ca 92011


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.